“Casa Romantica is committed to showcasing a wide range of visual arts,” explained Kylie Travis, Executive Director of Operations and Programming. “From photography and contemporary art to ...

The comedian traveled to Washington D.C. to speak with MAGA supporters about the new president. IndieWire can share an exclusive clip from the upcoming episode, which sees Klepper — a ...

First Lt. Manfredo Martin-Michael Madrigal III photographed as a staff sergeant in 2018. Madrigal pled guilty to making false statements and destroying U.S. Army materials. (Army) A former Army ...

Madrigal Pharma's REZDIFFRA achieved $100-$103M in Q4 sales, marking 61% growth, with market penetration of only 4% relative to TAM, indicating blockbuster potential. Potential competition from ...

The editorial board researches, interviews stakeholders and discusses issues of importance to Napa County residents. Its written opinions are the institutional views of the Napa Valley Register ...

The CASA Testing Centers have 120 testing stations in each of their locations, and currently offers testing for a multitude of courses at the University of Houston. Students who are required to take ...

Investor expectations may be too high, however. Madrigal unveiled those figures Monday morning. The company said that its preliminary results indicated it earned $100 million to $103 million in ...

Manfredo Martin-Michael Madrigal, 38, was handed a term of four years and six months Thursday during his sentencing in a federal court in Virginia, according to a Justice Department statement the ...

Manfredo Martin-Michael Madrigal, 38, also faced charges stemming from alleged harassment against two former girlfriends who were potential witnesses in the case. In court documents, one woman ...

The photo opportunity is part of the latest offering from Casa Romantica’s exhibition programming, an interactive exhibit unlike anything the Cultural Center and Gardens in San Clemente have ...

CEO Bill Sibold hailed 2024 as a "transformational year" for Madrigal Pharmaceuticals, but Wall Street isn't as enthusiastic about the company's sales results. CEO Bill Sibold hailed 2024 as a ...